false
OasisLMS
Catalog
Psychotropic Medications and Older Adults: Update ...
Presentation and Q&A
Presentation and Q&A
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses the use of psychotropic medications in older adults and provides an update on safety considerations. The video is presented by Donna Roland, Director of the Psychiatric Mental Health Nurse Practitioner Program at UT Austin, and a member of the clinical expert team for the Clinical Support System for Serious Mental Illness (CSS-SMI), a SAMHSA-funded initiative implemented by the American Psychiatric Association.<br /><br />The objectives of the video are to identify potentially inappropriate psychotropic medications for use in older adults, understand the pharmacodynamics and pharmacokinetics that require special considerations when prescribing psychotropic medications for older adults to prevent adverse drug events. The video also examines safety considerations, polypharmacy, and intentional deprescribing.<br /><br />The video starts with an overview of the epidemiology of psychiatric issues in geriatric patients, followed by a discussion on the pharmacodynamic and pharmacokinetic considerations as patients age. The video outlines the BRSAI criteria, FDA black box warnings, American Diabetes Association, and APA guidelines for best practices in the use of antipsychotics in older patients. Potentially inappropriate medications for use in this population are identified, and the video discusses the treatment of delirium, dementia, and behavioral disturbances. It also explores the appropriate management of anxiety and insomnia.<br /><br />The video concludes with case studies in outpatient, nursing home, and inpatient settings to illustrate the application of the discussed concepts. The importance of team management and the role of the Prescription Drug Monitoring Program (PDMP) are highlighted. The video emphasizes the need for a comprehensive approach to prescribing in older adults, including close collaboration with interdisciplinary teams and a focus on intentional deprescribing.<br /><br />No credits are mentioned in the video transcript.
Keywords
psychotropic medications
older adults
safety considerations
pharmacodynamics
pharmacokinetics
adverse drug events
polypharmacy
intentional deprescribing
geriatric patients
best practices
×
Please select your language
1
English